1. Stocks
    2. /
  2. Racura Oncology (ASX: RAC)
    3. /

Racura Oncology (ASX: RAC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Racura Oncology Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Racura Oncology (ASX: RAC)
    Latest News

    A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
    Healthcare Shares

    Why did the Race Oncology (ASX:RAC) share price drop 10% today?

    | Sebastian Bowen

    What happened with Race shares today?

    Read more »

    Lab technician analyses a sample in a laboratory for a clinical trial
    Healthcare Shares

    Race Oncology (ASX:RAC) share price rises following preclinical discovery

    | Alice de Bruin

    Shares in the oncology provider are up following an exciting discovery...

    Read more »

    A health professional wearing green scrubs and a face mask and stethoscope uses his mobile phone.
    Healthcare Shares

    In the green: Here are the 5 best ASX healthcare shares of 2021

    | Zach Bristow

    ASX healthcare shares were a strong bunch last year, with several majors and minors outperforming the primary indices.

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Here's why the Race Oncology (ASX:RAC) share price is edging higher

    | Aaron Teboneras

    The pharmaceutical company's shares are picking up steam on Tuesday. Here are the details

    Read more »

    A medical specialist holds a red heart connected via technology and artificial intelligence (AI)
    Healthcare Shares

    Here's why the Race Oncology (ASX:RAC) share price is climbing today

    | Monica O'Shea

    Why is Race Oncology making the heart tick today?

    Read more »

    A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
    Healthcare Shares

    Why is the Race Oncology (ASX:RAC) share price plunging 12% today?

    | Zach Bristow

    It hasn't been a good day for the precision oncology company.

    Read more »

    A young woman with tattoos puts both thumbs down and scrunches her face.
    Share Fallers

    Why Bapcor, Mayne Pharma, Race Oncology, and TechnologyOne shares are sinking

    | James Mickleboro

    These ASX shares are falling on Wednesday...

    Read more »

    man jumping along increasing bar graph signifying jump in alumina share price
    Healthcare Shares

    Racing higher: Race Oncology (ASX:RAC) share price jumps 13% on study breakthrough

    | Zach Bristow

    It was a good day for the healthcare company.

    Read more »

    Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
    Share Gainers

    Why the Race Oncology (ASX:RAC) share price is up on Monday

    | Zach Bristow

    There's more pipeline momentum out of Race's camp today.

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Healthcare Shares

    Race Oncology (ASX:RAC) share price struggles despite new Leukemia study

    | Aaron Teboneras

    Race Oncology is progressing with its Zantrene study.

    Read more »

    Three healthcare workers look and point at at medical image
    Healthcare Shares

    Race Oncology (ASX:RAC) share price edges higher amid patent update

    | Zach Bristow

    Race shares have moved into the green after a rollercoaster day so far...

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Share Gainers

    Why the Race Oncology (ASX:RAC) share price is storming higher today

    | James Mickleboro

    The Race Oncology share price is rising again...

    Read more »

    Frequently Asked Questions

    No, Racura Oncology does not pay dividends at this time.

    Sydney-headquartered Racura Oncology listed on the ASX on 13 July 2016.

    RAC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Racura Oncology

    Racura Oncology (ASX: RAC) is a Phase 3 clinical biopharmaceutical company with a dedicated mission to be at the heart of cancer care.

    Racura’s lead asset, RCDS1 (E,E-bisantrene), is a small molecule anticancer agent that primarily functions via G4-DNA & RNA binding, leading to potent inhibition of the important cancer growth regulator MYC. RCDS1 has demonstrated therapeutic activity in cancer patients with a well characterised safety profile. Recent discoveries made by Racura have enabled composition of matter IP filings that provide for 20 years of patent protection over RCDS1.

    Racura is advancing a proprietary formulation of RCDS1 (RC220) to address the high unmet needs of patients across multiple oncology indications, with Phase 3 clinical programs in acute myeloid leukaemia (AML), Phase 1a/b program in mutant epidermal growth factor receptor non-small cell lung cancer (EGFRm NSCLC), and a Phase 1a/b program in combination with the anthracycline doxorubicin, where we aim to deliver both cardioprotection and enhanced anticancer activity for solid tumour patients.

    Racura Oncology has collaborated with Astex, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong and University of Newcastle. Racura is actively exploring partnerships, licence agreements or a commercial merger and acquisition to accelerate access to RC220 for patients with cancer across the world.

    Profile

    since

    Note